- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Somatostatin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Somatostatin market size is estimated to be worth US$ 346.3 million in 2021 and is forecast to a readjusted size of USD 715 million by 2028 with a CAGR of 10.9% during review period. Hormonal Disorder accounting for % of the Somatostatin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 0.25mg/pcs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Somatostatin include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., and Polypeptide Laboratories, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Somatostatin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.25mg/pcs
0.75mg/pcs
3mg/pcs
Market segment by Application can be divided into
Hormonal Disorder
Oncology
Metabolic Disorder
Others
The key market players for global Somatostatin market are listed below:
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Somatostatin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2019 to 2022.
Chapter 3, the Somatostatin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Somatostatin.
Chapter 13, 14, and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Somatostatin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Somatostatin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 0.25mg/pcs
1.2.3 0.75mg/pcs
1.2.4 3mg/pcs
1.3 Market Analysis by Application
1.3.1 Overview: Global Somatostatin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Global Somatostatin Market Size & Forecast
1.4.1 Global Somatostatin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Somatostatin Sales in Volume (2017-2028)
1.4.3 Global Somatostatin Price (2017-2028)
1.5 Global Somatostatin Production Capacity Analysis
1.5.1 Global Somatostatin Total Production Capacity (2017-2028)
1.5.2 Global Somatostatin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Somatostatin Market Drivers
1.6.2 Somatostatin Market Restraints
1.6.3 Somatostatin Trends Analysis
2 Manufacturers Profiles
2.1 Merck (Schweiz) AG
2.1.1 Merck (Schweiz) AG Details
2.1.2 Merck (Schweiz) AG Major Business
2.1.3 Merck (Schweiz) AG Somatostatin Product and Services
2.1.4 Merck (Schweiz) AG Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 SANOFI-AVENTIS FRANCE
2.2.1 SANOFI-AVENTIS FRANCE Details
2.2.2 SANOFI-AVENTIS FRANCE Major Business
2.2.3 SANOFI-AVENTIS FRANCE Somatostatin Product and Services
2.2.4 SANOFI-AVENTIS FRANCE Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Lyomark Pharma GmbH
2.3.1 Lyomark Pharma GmbH Details
2.3.2 Lyomark Pharma GmbH Major Business
2.3.3 Lyomark Pharma GmbH Somatostatin Product and Services
2.3.4 Lyomark Pharma GmbH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 ALFA WASSERMANN S.p.A.
2.4.1 ALFA WASSERMANN S.p.A. Details
2.4.2 ALFA WASSERMANN S.p.A. Major Business
2.4.3 ALFA WASSERMANN S.p.A. Somatostatin Product and Services
2.4.4 ALFA WASSERMANN S.p.A. Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Polypeptide Laboratories, Inc
2.5.1 Polypeptide Laboratories, Inc Details
2.5.2 Polypeptide Laboratories, Inc Major Business
2.5.3 Polypeptide Laboratories, Inc Somatostatin Product and Services
2.5.4 Polypeptide Laboratories, Inc Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 SAMARTH
2.6.1 SAMARTH Details
2.6.2 SAMARTH Major Business
2.6.3 SAMARTH Somatostatin Product and Services
2.6.4 SAMARTH Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 UBPL
2.7.1 UBPL Details
2.7.2 UBPL Major Business
2.7.3 UBPL Somatostatin Product and Services
2.7.4 UBPL Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 HYBIO
2.8.1 HYBIO Details
2.8.2 HYBIO Major Business
2.8.3 HYBIO Somatostatin Product and Services
2.8.4 HYBIO Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 TianTaiShan
2.9.1 TianTaiShan Details
2.9.2 TianTaiShan Major Business
2.9.3 TianTaiShan Somatostatin Product and Services
2.9.4 TianTaiShan Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Yangtze River
2.10.1 Yangtze River Details
2.10.2 Yangtze River Major Business
2.10.3 Yangtze River Somatostatin Product and Services
2.10.4 Yangtze River Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Siyao
2.11.1 Siyao Details
2.11.2 Siyao Major Business
2.11.3 Siyao Somatostatin Product and Services
2.11.4 Siyao Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Shuangcheng
2.12.1 Shuangcheng Details
2.12.2 Shuangcheng Major Business
2.12.3 Shuangcheng Somatostatin Product and Services
2.12.4 Shuangcheng Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Hainan Zhonghe
2.13.1 Hainan Zhonghe Details
2.13.2 Hainan Zhonghe Major Business
2.13.3 Hainan Zhonghe Somatostatin Product and Services
2.13.4 Hainan Zhonghe Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 SL PHARM
2.14.1 SL PHARM Details
2.14.2 SL PHARM Major Business
2.14.3 SL PHARM Somatostatin Product and Services
2.14.4 SL PHARM Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Wuhan Hualong
2.15.1 Wuhan Hualong Details
2.15.2 Wuhan Hualong Major Business
2.15.3 Wuhan Hualong Somatostatin Product and Services
2.15.4 Wuhan Hualong Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Qingdao Guoda
2.16.1 Qingdao Guoda Details
2.16.2 Qingdao Guoda Major Business
2.16.3 Qingdao Guoda Somatostatin Product and Services
2.16.4 Qingdao Guoda Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Chengdu Shengnuo
2.17.1 Chengdu Shengnuo Details
2.17.2 Chengdu Shengnuo Major Business
2.17.3 Chengdu Shengnuo Somatostatin Product and Services
2.17.4 Chengdu Shengnuo Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Longjin
2.18.1 Longjin Details
2.18.2 Longjin Major Business
2.18.3 Longjin Somatostatin Product and Services
2.18.4 Longjin Somatostatin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Somatostatin Breakdown Data by Manufacturer
3.1 Global Somatostatin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Somatostatin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Somatostatin
3.4 Market Concentration Rate
3.4.1 Top 3 Somatostatin Manufacturer Market Share in 2021
3.4.2 Top 6 Somatostatin Manufacturer Market Share in 2021
3.5 Global Somatostatin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Somatostatin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Somatostatin Market Size by Region
4.1.1 Global Somatostatin Sales in Volume by Region (2017-2028)
4.1.2 Global Somatostatin Revenue by Region (2017-2028)
4.2 North America Somatostatin Revenue (2017-2028)
4.3 Europe Somatostatin Revenue (2017-2028)
4.4 Asia-Pacific Somatostatin Revenue (2017-2028)
4.5 South America Somatostatin Revenue (2017-2028)
4.6 Middle East and Africa Somatostatin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Somatostatin Sales in Volume by Type (2017-2028)
5.2 Global Somatostatin Revenue by Type (2017-2028)
5.3 Global Somatostatin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Somatostatin Sales in Volume by Application (2017-2028)
6.2 Global Somatostatin Revenue by Application (2017-2028)
6.3 Global Somatostatin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Somatostatin Sales by Type (2017-2028)
7.2 North America Somatostatin Sales by Application (2017-2028)
7.3 North America Somatostatin Market Size by Country
7.3.1 North America Somatostatin Sales in Volume by Country (2017-2028)
7.3.2 North America Somatostatin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Somatostatin Sales by Type (2017-2028)
8.2 Europe Somatostatin Sales by Application (2017-2028)
8.3 Europe Somatostatin Market Size by Country
8.3.1 Europe Somatostatin Sales in Volume by Country (2017-2028)
8.3.2 Europe Somatostatin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Somatostatin Sales by Type (2017-2028)
9.2 Asia-Pacific Somatostatin Sales by Application (2017-2028)
9.3 Asia-Pacific Somatostatin Market Size by Region
9.3.1 Asia-Pacific Somatostatin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Somatostatin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Somatostatin Sales by Type (2017-2028)
10.2 South America Somatostatin Sales by Application (2017-2028)
10.3 South America Somatostatin Market Size by Country
10.3.1 South America Somatostatin Sales in Volume by Country (2017-2028)
10.3.2 South America Somatostatin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Somatostatin Sales by Type (2017-2028)
11.2 Middle East & Africa Somatostatin Sales by Application (2017-2028)
11.3 Middle East & Africa Somatostatin Market Size by Country
11.3.1 Middle East & Africa Somatostatin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Somatostatin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Somatostatin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Somatostatin
12.3 Somatostatin Production Process
12.4 Somatostatin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Somatostatin Typical Distributors
13.3 Somatostatin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Somatostatin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Somatostatin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck (Schweiz) AG Basic Information, Manufacturing Base and Competitors
Table 4. Merck (Schweiz) AG Major Business
Table 5. Merck (Schweiz) AG Somatostatin Product and Services
Table 6. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. SANOFI-AVENTIS FRANCE Basic Information, Manufacturing Base and Competitors
Table 8. SANOFI-AVENTIS FRANCE Major Business
Table 9. SANOFI-AVENTIS FRANCE Somatostatin Product and Services
Table 10. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Lyomark Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 12. Lyomark Pharma GmbH Major Business
Table 13. Lyomark Pharma GmbH Somatostatin Product and Services
Table 14. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. ALFA WASSERMANN S.p.A. Basic Information, Manufacturing Base and Competitors
Table 16. ALFA WASSERMANN S.p.A. Major Business
Table 17. ALFA WASSERMANN S.p.A. Somatostatin Product and Services
Table 18. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Polypeptide Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Polypeptide Laboratories, Inc Major Business
Table 21. Polypeptide Laboratories, Inc Somatostatin Product and Services
Table 22. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. SAMARTH Basic Information, Manufacturing Base and Competitors
Table 24. SAMARTH Major Business
Table 25. SAMARTH Somatostatin Product and Services
Table 26. SAMARTH Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. UBPL Basic Information, Manufacturing Base and Competitors
Table 28. UBPL Major Business
Table 29. UBPL Somatostatin Product and Services
Table 30. UBPL Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. HYBIO Basic Information, Manufacturing Base and Competitors
Table 32. HYBIO Major Business
Table 33. HYBIO Somatostatin Product and Services
Table 34. HYBIO Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. TianTaiShan Basic Information, Manufacturing Base and Competitors
Table 36. TianTaiShan Major Business
Table 37. TianTaiShan Somatostatin Product and Services
Table 38. TianTaiShan Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Yangtze River Basic Information, Manufacturing Base and Competitors
Table 40. Yangtze River Major Business
Table 41. Yangtze River Somatostatin Product and Services
Table 42. Yangtze River Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Siyao Basic Information, Manufacturing Base and Competitors
Table 44. Siyao Major Business
Table 45. Siyao Somatostatin Product and Services
Table 46. Siyao Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Shuangcheng Basic Information, Manufacturing Base and Competitors
Table 48. Shuangcheng Major Business
Table 49. Shuangcheng Somatostatin Product and Services
Table 50. Shuangcheng Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Hainan Zhonghe Basic Information, Manufacturing Base and Competitors
Table 52. Hainan Zhonghe Major Business
Table 53. Hainan Zhonghe Somatostatin Product and Services
Table 54. Hainan Zhonghe Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. SL PHARM Basic Information, Manufacturing Base and Competitors
Table 56. SL PHARM Major Business
Table 57. SL PHARM Somatostatin Product and Services
Table 58. SL PHARM Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Wuhan Hualong Basic Information, Manufacturing Base and Competitors
Table 60. Wuhan Hualong Major Business
Table 61. Wuhan Hualong Somatostatin Product and Services
Table 62. Wuhan Hualong Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Qingdao Guoda Basic Information, Manufacturing Base and Competitors
Table 64. Qingdao Guoda Major Business
Table 65. Qingdao Guoda Somatostatin Product and Services
Table 66. Qingdao Guoda Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Chengdu Shengnuo Basic Information, Manufacturing Base and Competitors
Table 68. Chengdu Shengnuo Major Business
Table 69. Chengdu Shengnuo Somatostatin Product and Services
Table 70. Chengdu Shengnuo Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Longjin Basic Information, Manufacturing Base and Competitors
Table 72. Longjin Major Business
Table 73. Longjin Somatostatin Product and Services
Table 74. Longjin Somatostatin Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Somatostatin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 76. Global Somatostatin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Somatostatin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Somatostatin Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 79. Head Office and Somatostatin Production Site of Key Manufacturer
Table 80. Somatostatin New Entrant and Capacity Expansion Plans
Table 81. Somatostatin Mergers & Acquisitions in the Past Five Years
Table 82. Global Somatostatin Sales by Region (2017-2022) & (K Pcs)
Table 83. Global Somatostatin Sales by Region (2023-2028) & (K Pcs)
Table 84. Global Somatostatin Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Somatostatin Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 87. Global Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 88. Global Somatostatin Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Somatostatin Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Somatostatin Price by Type (2017-2022) & (USD/Pcs)
Table 91. Global Somatostatin Price by Type (2023-2028) & (USD/Pcs)
Table 92. Global Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 93. Global Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 94. Global Somatostatin Revenue by Application (2017-2022) & (USD Million)
Table 95. Global Somatostatin Revenue by Application (2023-2028) & (USD Million)
Table 96. Global Somatostatin Price by Application (2017-2022) & (USD/Pcs)
Table 97. Global Somatostatin Price by Application (2023-2028) & (USD/Pcs)
Table 98. North America Somatostatin Sales by Country (2017-2022) & (K Pcs)
Table 99. North America Somatostatin Sales by Country (2023-2028) & (K Pcs)
Table 100. North America Somatostatin Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Somatostatin Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 103. North America Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 104. North America Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 105. North America Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 106. Europe Somatostatin Sales by Country (2017-2022) & (K Pcs)
Table 107. Europe Somatostatin Sales by Country (2023-2028) & (K Pcs)
Table 108. Europe Somatostatin Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Somatostatin Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 111. Europe Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 112. Europe Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 113. Europe Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 114. Asia-Pacific Somatostatin Sales by Region (2017-2022) & (K Pcs)
Table 115. Asia-Pacific Somatostatin Sales by Region (2023-2028) & (K Pcs)
Table 116. Asia-Pacific Somatostatin Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Somatostatin Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 119. Asia-Pacific Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 120. Asia-Pacific Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 121. Asia-Pacific Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 122. South America Somatostatin Sales by Country (2017-2022) & (K Pcs)
Table 123. South America Somatostatin Sales by Country (2023-2028) & (K Pcs)
Table 124. South America Somatostatin Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Somatostatin Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 127. South America Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 128. South America Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 129. South America Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 130. Middle East & Africa Somatostatin Sales by Region (2017-2022) & (K Pcs)
Table 131. Middle East & Africa Somatostatin Sales by Region (2023-2028) & (K Pcs)
Table 132. Middle East & Africa Somatostatin Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Somatostatin Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Somatostatin Sales by Type (2017-2022) & (K Pcs)
Table 135. Middle East & Africa Somatostatin Sales by Type (2023-2028) & (K Pcs)
Table 136. Middle East & Africa Somatostatin Sales by Application (2017-2022) & (K Pcs)
Table 137. Middle East & Africa Somatostatin Sales by Application (2023-2028) & (K Pcs)
Table 138. Somatostatin Raw Material
Table 139. Key Manufacturers of Somatostatin Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Somatostatin Typical Distributors
Table 143. Somatostatin Typical Customers
List of Figures
Figure 1. Somatostatin Picture
Figure 2. Global Somatostatin Revenue Market Share by Type in 2021
Figure 3. 0.25mg/pcs
Figure 4. 0.75mg/pcs
Figure 5. 3mg/pcs
Figure 6. Global Somatostatin Revenue Market Share by Application in 2021
Figure 7. Hormonal Disorder
Figure 8. Oncology
Figure 9. Metabolic Disorder
Figure 10. Others
Figure 11. Global Somatostatin Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 12. Global Somatostatin Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Somatostatin Sales (2017-2028) & (K Pcs)
Figure 14. Global Somatostatin Price (2017-2028) & (USD/Pcs)
Figure 15. Global Somatostatin Production Capacity (2017-2028) & (K Pcs)
Figure 16. Global Somatostatin Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Somatostatin Market Drivers
Figure 18. Somatostatin Market Restraints
Figure 19. Somatostatin Market Trends
Figure 20. Global Somatostatin Sales Market Share by Manufacturer in 2021
Figure 21. Global Somatostatin Revenue Market Share by Manufacturer in 2021
Figure 22. Somatostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Somatostatin Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Somatostatin Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Somatostatin Sales Market Share by Region (2017-2028)
Figure 26. Global Somatostatin Revenue Market Share by Region (2017-2028)
Figure 27. North America Somatostatin Revenue (2017-2028) & (USD Million)
Figure 28. Europe Somatostatin Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Somatostatin Revenue (2017-2028) & (USD Million)
Figure 30. South America Somatostatin Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Somatostatin Revenue (2017-2028) & (USD Million)
Figure 32. Global Somatostatin Sales Market Share by Type (2017-2028)
Figure 33. Global Somatostatin Revenue Market Share by Type (2017-2028)
Figure 34. Global Somatostatin Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Somatostatin Sales Market Share by Application (2017-2028)
Figure 36. Global Somatostatin Revenue Market Share by Application (2017-2028)
Figure 37. Global Somatostatin Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Somatostatin Sales Market Share by Type (2017-2028)
Figure 39. North America Somatostatin Sales Market Share by Application (2017-2028)
Figure 40. North America Somatostatin Sales Market Share by Country (2017-2028)
Figure 41. North America Somatostatin Revenue Market Share by Country (2017-2028)
Figure 42. United States Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Somatostatin Sales Market Share by Type (2017-2028)
Figure 46. Europe Somatostatin Sales Market Share by Application (2017-2028)
Figure 47. Europe Somatostatin Sales Market Share by Country (2017-2028)
Figure 48. Europe Somatostatin Revenue Market Share by Country (2017-2028)
Figure 49. Germany Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Somatostatin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Somatostatin Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Somatostatin Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Somatostatin Revenue Market Share by Region (2017-2028)
Figure 58. China Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Somatostatin Sales Market Share by Type (2017-2028)
Figure 65. South America Somatostatin Sales Market Share by Application (2017-2028)
Figure 66. South America Somatostatin Sales Market Share by Country (2017-2028)
Figure 67. South America Somatostatin Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Somatostatin Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Somatostatin Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Somatostatin Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Somatostatin Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Somatostatin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Somatostatin in 2021
Figure 79. Manufacturing Process Analysis of Somatostatin
Figure 80. Somatostatin Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
